Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007

23 Oct 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer-related Molecular Pathways
Share to RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29069577
DOI: 10.1016/j.canlet.2017.09.053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007PMID 29069577Read ↗

p53 as a potential target in cancer therapy.Semantic proximity Read ↗

Role of p53 in breast cancer progression: An insight into p53 targeted therapy.Semantic proximity Read ↗

Mutant p53 in breast cancer: potential as a therapeutic target and biomarker.Semantic proximity Read ↗

p53 as a target for the treatment of cancer.Semantic proximity Read ↗

Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic StrategiesSemantic proximity Read ↗

p53: a target for new anticancer drugs or a target for old drugs?Semantic proximity Read ↗

Attenuation of p53 mutant as an approach for treatment Her2-positive cancerSemantic proximity Read ↗

The triple-negative subtype: new ideas for the poorest prognosis breast cancer.Semantic proximity Read ↗

Inhibition of GPX4 Induces the Death of p53-Mutant Triple-Negative Breast Cancer CellsSemantic proximity Read ↗

Inhibition of GPX4 Induces the Death of p53-Mutant Triple-Negative Breast CancerSemantic proximity Read ↗

Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?Semantic proximity Read ↗

Drugging the p53 pathway: understanding the route to clinical efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.